Report Detail
Hereditary Cancer Testing Market to 2027 - Global Analysis and Forecasts By Diagnosis Type (Biopsy, Imaging); Technology (Sequencing, PCR, Microarray); End User (Hospital, Clinics, Diagnostic Centers), and Geography
- RnM3806337 |
- 07 October, 2019 |
- Global |
- 171 Pages |
- The Insight Partners |
- Biotechnology
The global hereditary cancer testing market is expected to reach US$ 9,840.52 Mn in 2027 from US$ 3,967.74 Mn in 2018. The market is estimated to grow with a CAGR of 11.1% from 2019-2027.
The market for hereditary cancer testing is expected to grow, owing to factors such as increasing prevalence of hereditary cancer and growing awareness about hereditary cancer have been boosting the market over the years. In addition, the growing demand for noninvasive methods of detection are likely to have a positive impact on the growth of the market in the coming years. However, problems in accessing whole genomic data for early detection are likely to have a negative impact on the growth of the market in the coming years.
Genetic testing helps evaluate the chance of developing cancer in a lifetime. The genetic testing is done by searching for specific mutations in genes, chromosomes, or proteins. An inherited gene mutation causes hereditary cancer. An inherited gene is the one which is passed from parent to child in a family. Various methods are used for hereditary cancer testing; it includes genetic counseling. The counseling provides a discussion regarding recommendations for preventive care and screening with the patient. They support groups and other information resources and provide emotional support to the person getting the results.
Genomic analysis is used to monitor, diagnose, treat, forecast, and prevent diseases, and promote good health in persons. The technological advances have allowed more significant integration of genomics into health care delivery, facilitating screening and molecular diagnostics along with the precise detection of microbes, and prescription and monitoring of efficiency of more accurate therapeutics. Moreover, the genome-based approaches deliver advantages, and it also come with new susceptibilities and risks concerning cybersecurity. The dependency on genome databases restricts the cyber-attacks by conceding their integrity, taking them hostage, or manipulating the data they contain. Therefore, the problem in accessing the whole genomic data for early detection is expected to create a negative impact on the overall industry at a certain extent.
Global hereditary cancer testing market is segmented by diagnosis type, technology, and end user. On the basis of diagnosis type, the market is segmented into biopsy and imaging. On the basis of technology, the market is segmented into sequencing, PCR, and microarray. Based on end user, the market is segmented into diagnostic centers, hospital, and clinics. In 2018, the imaging held the largest share in the market, by diagnosis type.
Some of the major primary and secondary sources included in the report are, Food and Drug Administration, World Health Organization (WHO), Centers for Medicare & Medicaid Services (CMS), National Institute of Cancer Prevention and Research (NICPR), National Cancer Institute, Canadian Institutes of Health Research (CIHR), Spanish Society of Medical Oncology (SEOM), and others.
TABLE OF CONTENTS
1. Introduction
- 1.1 Scope of the Study
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 Global Hereditary Cancer Testing Market - By Diagnosis Type
- 1.3.2 Global Hereditary Cancer Testing Market - By Technology
- 1.3.3 Global Hereditary Cancer Testing Market - By End User
- 1.3.4 Global Hereditary Cancer Testing Market - By Geography
2. Global Hereditary Cancer Testing Market - Key Takeaways
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. Global Hereditary Cancer Testing Market - Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
- 4.2.2 Europe PEST Analysis
- 4.2.3 Asia Pacific PEST Analysis
- 4.2.4 Middle East & Africa PEST Analysis
- 4.2.5 South & Central America PEST Analysis
- 4.3 Expert Opinions
- 4.4 Hereditary Cancer Testing - Price Analysis (US$)
- 4.5 Reimbursement Scenario (US)
- 4.6 Population Screening Data
5. Global Hereditary Cancer Testing Market - Key Industry Dynamics
- 5.1 Key Market Drivers
- 5.1.1 Increasing Prevalence of Hereditary Cancer
- 5.1.2 Growing Awareness About Hereditary Cancer
- 5.2 Key Market Restraints
- 5.2.1 Problems in Accessing Whole Genomic Data for Early Detection
- 5.3 Key Market Opportunities
- 5.3.1 Growing Demand for Noninvasive Methods of Detection
- 5.4 Future Trends
- 5.4.1 Preference For Personalized Medicines
- 5.5 Impact Analysis
6. Hereditary Cancer Testing Market - Global Analysis
- 6.1 Global Hereditary Cancer Testing Market Revenue Forecasts And Analysis
- 6.2 Global Hereditary Cancer Testing Market, By Geography - Forecasts And Analysis
- 6.3 Performance of Key Players
7. Global Hereditary Cancer Testing Market Analysis- by Diagnosis Type
- 7.1 Overview
- 7.2 Global Hereditary Cancer Testing Market, By Diagnosis Type 2018 & 2027 (%)
- 7.3 Biopsy Market
- 7.3.1 Overview
- 7.3.2 Global Biopsy Market Revenue and Forecasts to 2027 (US$ Mn)
- 7.3.3 Blood Sample Market
- 7.3.3.1 Overview
- 7.3.3.2 Global Blood Sample Market Revenue and Forecasts to 2027 (US$ Mn)
- 7.3.4 Cheek Swab Sample Market
- 7.3.4.1 Overview
- 7.3.4.2 Global Cheek Swab Sample Market Revenue and Forecasts to 2027 (US$ Mn)
- 7.4 Imaging Market
- 7.4.1 Overview
- 7.4.2 Global Imaging Market Revenue and Forecasts to 2027 (US$ Mn)
8. Global Hereditary Cancer Testing Market Analysis- by Technology
- 8.1 Overview
- 8.2 Global Hereditary Cancer Testing Market, By Technology 2018 & 2027 (%)
- 8.3 Sequencing Market
- 8.3.1 Overview
- 8.3.2 Global Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.4 Polymerase Chain Reaction (PCR) Market
- 8.4.1 Overview
- 8.4.2 Global Polymerase Chain Reaction (PCR) Market Revenue and Forecasts to 2027 (US$ Mn)
- 8.5 Microarray Market
- 8.5.1 Overview
- 8.5.2 Global Microarray Market Revenue and Forecasts to 2027 (US$ Mn)
9. Global Hereditary Cancer Testing Market Analysis - by End User
- 9.1 Overview
- 9.2 Global Hereditary Cancer Testing Market, By End User 2018 & 2027 (%)
- 9.3 Diagnostic Centers Market
- 9.3.1 Overview
- 9.3.2 Global Diagnostic Centers Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.4 Hospitals Market
- 9.4.1 Overview
- 9.4.2 Global Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
- 9.5 Clinics Market
- 9.5.1 Overview
- 9.5.2 Global Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
10. Hereditary Cancer Testing Market Revenue and Forecasts to 2027 - Geographical Analysis
- 10.1 North America Hereditary Cancer Testing Market
- 10.1.1 Overview
- 10.1.2 North America Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.1.3 North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
- 10.1.3.1 North America Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
- 10.1.4 North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
- 10.1.5 North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.1.6 North America Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
- 10.1.7 US Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.1.7.1 US Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.1.7.2 US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
- 10.1.7.2.1 US Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
- 10.1.7.3 US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
- 10.1.7.4 US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.1.8 Canada Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.1.8.1 Canada Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.1.8.2 Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
- 10.1.8.2.1 Canada Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
- 10.1.8.3 Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
- 10.1.8.4 Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.1.9 Mexico Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.1.9.1 Mexico Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.1.9.2 Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
- 10.1.9.2.1 Mexico Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
- 10.1.9.3 Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
- 10.1.9.4 Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.2 Europe Hereditary Cancer Testing Market
- 10.2.1 Overview
- 10.2.2 Europe Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.2.3 Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
- 10.2.3.1 Europe Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
- 10.2.4 Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
- 10.2.5 Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.2.6 Europe Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
- 10.2.7 UK Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.2.7.1 UK Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.2.7.2 UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
- 10.2.7.2.1 UK Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
- 10.2.7.3 UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
- 10.2.7.4 UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.2.8 Germany Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.2.8.1 Germany Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.2.8.2 Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
- 10.2.8.2.1 Germany Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
- 10.2.8.3 Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
- 10.2.8.4 Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.2.9 France Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.2.9.1 France Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.2.9.2 France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
- 10.2.9.2.1 France Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
- 10.2.9.3 France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
- 10.2.9.4 France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.2.10 Italy Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.2.10.1 Italy Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.2.10.2 Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
- 10.2.10.2.1 Italy Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
- 10.2.10.3 Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
- 10.2.10.4 Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.2.11 Spain Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.2.11.1 Spain Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.2.11.2 Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
- 10.2.11.2.1 Spain Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
- 10.2.11.3 Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
- 10.2.11.4 Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.3 Asia Pacific Hereditary Cancer Testing Market
- 10.3.1 Overview
- 10.3.2 Asia Pacific Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.3.3 Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
- 10.3.3.1 Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
- 10.3.4 Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
- 10.3.5 Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.3.6 Asia Pacific Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
- 10.3.7 China Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.3.7.1 China Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.3.7.2 China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
- 10.3.7.2.1 China Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
- 10.3.7.3 China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
- 10.3.7.4 China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.3.8 India Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.3.8.1 India Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.3.8.2 India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
- 10.3.8.2.1 India Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
- 10.3.8.3 India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
- 10.3.8.4 India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.3.9 Japan Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.3.9.1 Japan Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.3.9.2 Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
- 10.3.9.2.1 Japan Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
- 10.3.9.3 Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
- 10.3.9.4 Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.3.10 Australia Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.3.10.1 Australia Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.3.10.2 Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
- 10.3.10.2.1 Australia Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
- 10.3.10.3 Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
- 10.3.10.4 Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.3.11 South Korea Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.3.11.1 South Korea Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.3.11.2 South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
- 10.3.11.2.1 South Korea Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
- 10.3.11.3 South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
- 10.3.11.4 South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.4 Middle East & Africa Hereditary Cancer Testing Market
- 10.4.1 Overview
- 10.4.2 Middle East & Africa Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.4.3 Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
- 10.4.3.1 Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
- 10.4.4 Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
- 10.4.5 Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.4.6 Middle East & Africa Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
- 10.4.7 South Africa Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.4.7.1 South Africa Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.4.7.2 South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
- 10.4.7.2.1 South Africa Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
- 10.4.7.3 South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
- 10.4.7.4 South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.4.8 Saudi Arabia Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.4.8.1 Saudi Arabia Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.4.8.2 Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
- 10.4.8.2.1 Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
- 10.4.8.3 Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
- 10.4.8.4 Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.4.9 UAE Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.4.9.1 UAE Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.4.9.2 UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
- 10.4.9.2.1 UAE Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
- 10.4.9.3 UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
- 10.4.9.4 UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.5 South And Central America Hereditary Cancer Testing Market
- 10.5.1 Overview
- 10.5.2 South and Central America Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.5.3 South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
- 10.5.3.1 South and Central America Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
- 10.5.4 South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
- 10.5.5 South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.5.6 South and Central America Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
- 10.5.7 Argentina Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.5.7.1 Argentina Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.5.7.2 Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
- 10.5.7.2.1 Argentina Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
- 10.5.7.3 Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
- 10.5.7.4 Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
- 10.5.8 Brazil Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.5.8.1 Brazil Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
- 10.5.8.2 Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
- 10.5.8.2.1 Brazil Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
- 10.5.8.3 Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
- 10.5.8.4 Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11. Hereditary Cancer Testing Market - Industry Landscape
- 11.1 Overview
- 11.2 Growth Strategies in the Hereditary Cancer Testing Market, 2016-2019
- 11.3 Organic Growth Strategies
- 11.3.1 Overview
- 11.3.2 Product Launch
- 11.3.3 Product Approval
- 11.3.4 Others
- 11.4 Inorganic Growth Strategies
- 11.4.1 Overview
- 11.4.2 Partnership
- 11.4.3 Agreement & Collaboration
- 11.4.4 Acquisition
12. Hereditary Cancer Testing Market-Key Company Profiles
- 12.1 Hologic Inc.
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Financial Overview
- 12.1.4 Product Portfolio
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 Koninklijke Philips N.V.
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Financial Overview
- 12.2.4 Product Portfolio
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 Quest Diagnostics Incorporated
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Financial Overview
- 12.3.4 Product Portfolio
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 Myriad Genetics, Inc.
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Financial Overview
- 12.4.4 Product Portfolio
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Cancer Genetics Inc.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Financial Overview
- 12.5.4 Product Portfolio
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 Invitae Corporation
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Financial Overview
- 12.6.4 Product Portfolio
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 Myogenes
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Financial Overview
- 12.7.4 Product Portfolio
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 Strand Life Sciences Pvt. Ltd.
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Financial Overview
- 12.8.4 Product Portfolio
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
- 12.9 Pathway Genomics Corporation
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Financial Overview
- 12.9.4 Product Portfolio
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
- 12.10 CENTOGENE AG
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Financial Overview
- 12.10.4 Product Portfolio
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. Appendix
- 13.1 About The Insight Partners
Summary:
Get latest Market Research Reports on Hereditary Cancer Testing . Industry analysis & Market Report on Hereditary Cancer Testing is a syndicated market report, published as Hereditary Cancer Testing Market to 2027 - Global Analysis and Forecasts By Diagnosis Type (Biopsy, Imaging); Technology (Sequencing, PCR, Microarray); End User (Hospital, Clinics, Diagnostic Centers), and Geography . It is complete Research Study and Industry Analysis of Hereditary Cancer Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
